re: settlement ? King Gee right:British conglomerate Glaxo (GSK) declined 2% to $49.16 in the wake of a request by the Food and Drug Administration that it put warnings on the labels of its asthma drugs Severent and Advair advising they can trigger deadly asthma attacks in some users. Advair is one of Glaxo's most lucrative drugs. See full story.